Trial Profile
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirasemtiv (Primary)
- Indications Intermittent claudication
- Focus Therapeutic Use
- Sponsors Cytokinetics
- 24 Nov 2014 New trial record